Literature DB >> 19635438

Nosocomial candidemia at a general hospital: the change of epidemiological and clinical characteristics. A comparative study of 2 cohorts (1993-1998 versus 2002-2005).

Joaquín Gómez1, Elisa García-Vázquez, Cristina Espinosa, Joaquín Ruiz, Manuel Canteras, Alicia Hernández-Torres, Victor Baños, José Antonio Herrero, Mariano Valdés.   

Abstract

BACKGROUND: Nosocomial candidemia (NC) is associated with high mortality, increased hospital stay and greater economical cost. AIMS: To evaluate epidemiological and clinical aspects of 2 different cohorts of non-paediatric patients with NC.
METHODS: A retrospective observational and comparative study of patients with NC. Patients were identified by review of results of blood cultures from the hospital microbiology laboratory. We analysed epidemiological, clinical, microbiological and laboratory data and changes in the 2 cohorts: 1993-1998 (P1) and from 2002 to 2005 (P2).
RESULTS: Eighty patients were studied during P1 and 107 during P2; incidence was 9/10,000 in P1 and 15.8/10,000 admitted patients in P2 (p<0.05). Mean age was 52 years in P1 and 61 years in P2 (p<0.05); 66% and 49% NC were due to Candida albicans in P1 and P2, respectively (p<0.05); diabetes was present in 12% in P1 and in 25% in P2 (p<0.05). All of the patients had previously received at least one course of broad-spectrum antibiotics. A statistically significant difference (p<0.05) in predisposing conditions was identified in central intravenous line rate (100% in P1 and 91% in P2) and previous surgery (43% in P1 and 78% in P2). Acute severity of illness at onset and complications were more frequent in P2 (p<0.05). Mortality rate was similar in P1 and P2 (51% and 49.5%, respectively).
CONCLUSIONS: Frequency of NC has increased and non-albicans Candida is now more frequent than C. albicans. Although acute severity of illness at onset and complications are now more frequent, mortality remains the same.

Entities:  

Mesh:

Year:  2009        PMID: 19635438     DOI: 10.1016/j.riam.2009.02.003

Source DB:  PubMed          Journal:  Rev Iberoam Micol        ISSN: 1130-1406            Impact factor:   1.044


  8 in total

1.  Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.

Authors:  Emilia Cantón; Javier Pemán; Guillermo Quindós; Elena Eraso; Ilargi Miranda-Zapico; María Álvarez; Paloma Merino; Isolina Campos-Herrero; Francesc Marco; Elia Gomez G de la Pedrosa; Genoveva Yagüe; Remedios Guna; Carmen Rubio; Consuelo Miranda; Carmen Pazos; David Velasco
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Chitosan-EDTA new combination is a promising candidate for treatment of bacterial and fungal infections.

Authors:  Amany A El-Sharif; Mohamed H M Hussain
Journal:  Curr Microbiol       Date:  2010-10-21       Impact factor: 2.188

3.  Six-year trend analysis of nosocomial candidemia and risk factors in two intensive care hospitals in Mato Grosso, midwest region of Brazil.

Authors:  Hugo Dias Hoffmann-Santos; Claudete Rodrigues Paula; Ana Caroline Akeme Yamamoto; Tomoko Tadano; Rosane C Hahn
Journal:  Mycopathologia       Date:  2013-10-11       Impact factor: 2.574

4.  Hemolytic factor production by clinical isolates of Candida species.

Authors:  Daniel Favero; Luciana Furlaneto-Maia; Emanuele J G França; Helena Peggau Góes; Marcia Cristina Furlaneto
Journal:  Curr Microbiol       Date:  2013-09-19       Impact factor: 2.188

5.  Evaluation of PNA-FISH yeast traffic light for rapid identification of yeast directly from positive blood cultures and assessment of clinical impact.

Authors:  N R H Stone; R L Gorton; K Barker; P Ramnarain; C C Kibbler
Journal:  J Clin Microbiol       Date:  2013-02-06       Impact factor: 5.948

6.  Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in Shanghai.

Authors:  Zhi-Tao Yang; Lin Wu; Xiao-Ying Liu; Min Zhou; Jie Li; Jia-Yin Wu; Yong Cai; En-Qiang Mao; Er-Zhen Chen; Olivier Lortholary
Journal:  BMC Infect Dis       Date:  2014-05-06       Impact factor: 3.090

7.  Microdilution in vitro Antifungal Susceptibility Patterns of Candida Species, From Mild Cutaneous to Bloodstream Infections.

Authors:  Elham Rezazadeh; Azar Sabokbar; Maryam Moazeni; Mohammad Sadegh Rezai; Hamid Badali
Journal:  Jundishapur J Microbiol       Date:  2016-07-05       Impact factor: 0.747

8.  Identification of Cryptic Species of Four Candida Complexes in a Culture Collection.

Authors:  Gustavo Fontecha; Kathy Montes; Bryan Ortiz; Celeste Galindo; Sharleen Braham
Journal:  J Fungi (Basel)       Date:  2019-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.